As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...

Veteran financial expert Stacy Johnson shares a five-point strategy for navigating market downturns, emphasizing maintaining ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

Dr Reddy's CFO Narasimham recently told to Moneycontrol he is confident of 'sustained double-digit sales growth' in FY26, ...

Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

MBX Biosciences is advancing a unique prodrug pipeline with key GLP-1 assets and a pivotal Phase 2 readout in ...

To discuss The Future of Scotch Whisky in Changing Times, McLaren Packaging, in association with The Scotsman, recently ...

To discuss The Future of Scotch Whisky in Changing Times, McLaren Packaging, in association with The Scotsman, recently ...

Another is to find stocks with relatively affordable price tags per share. Although it's sometimes the case that the most ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...